Patients with systemic lupus erythematosus (SLE) who test positive for antiphospholipid antibodies (aPLs) are at a significantly higher risk of developing diffuse alveolar hemorrhage (DAH), according ...

Researchers identified 3 distinct PsA phenotype clusters, emphasizing the importance of PsO severity in treatment decision making.

Disease-modifying therapy use for MS in pregnancy is associated with certain adverse outcomes, including small for gestational age.

Topline data were announced from two phase 3 trials evaluating deucravacitinib in adults with active psoriatic arthritis.

COVID-19 infection is associated with accelerated decline in kidney function, especially after hospitalization.

There is a bidirectional association between rheumatoid arthritis (RA) and chronic obstructive pulmonary disease (COPD).

Severe maternal morbidity events in first pregnancy were associated with a significantly reduced likelihood of subsequent delivery.

The FDA has approved Steqeyma® (ustekinumab-stba), a biosimilar to Stelara®, for the treatment of various chronic ...

A recent study finds that the prevalence of post-COVID-19 condition was 8.4 percent among U.S. adults in 2023.

Topline data were announced from a phase 3 trial evaluating CagriSema in overweight or obese patients without type 2 diabetes.

COVID-19 infection is not associated with immediate changes in multiple sclerosis symptom severity or disability.

For patients with ulcerative colitis, upadacitinib is associated with improved disease-specific outcomes compared with tofacitinib.